iovel Combination Tablets special drug use surveillance Long-term use in patients with type 2 diabetes mellitus
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-jRCT1080222253
- Lead Sponsor
- TAKEDA PHARMACEUTICAL COMPANY LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 3000
Patients with type 2 diabetes mellitus
Patients meeting any of the following criteria will be excluded:
1. Patients with current cardiac failure or a past history of cardiac failure
2. Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus
3. Patients with serious hepatic dysfunction
4. Patients with serious renal dysfunction
5. Patients with severe infection, pre- or post-operative patients, or patients with serious traumatic injury
6. Patients with a history of hypersensitivity to any ingredients of Liovel
7. Pregnant or possibly pregnant wome
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method